Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome

Pharmacological Research

Volumn 123, Issue , 2017, Pages 114-121

  Labazi, Hicham ^a   Trask, Aaron J ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTERIAL STIFFNESS; BLOOD VESSEL TONE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HEART DISEASE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; VASCULITIS; ANIMAL; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; DIABETES MELLITUS, TYPE 2; HEART DISEASES; HUMANS; METABOLIC SYNDROME; MICROCIRCULATION; MICROVESSELS;

EID: 85024115419     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2017.07.004     Document Type: Review

References (106)

1. Prasad, A.M., Ketsawatsomkron, P., Nuno, D.W., Koval, O.M., Dibbern, M.E., Venema, A.N., Sigmund, C.D., Lamping, K.G., Grumbach, I.M., Role of CaMKII in Ang-II-dependent small artery remodeling. Vascul. Pharmacol., 2016.
2. Bender, S.B., Castorena-Gonzalez, J.A., Garro, M., Reyes-Aldasoro, C.C., Sowers, J.R., DeMarco, V.G., Martinez-Lemus, L.A., Regional variation in arterial stiffening and dysfunction in Western diet-induced obesity. Am. J. Physiol. Heart Circ. Physiol. 309:4 (2015), H574–582.
3. Trask, A.J., Delbin, M.A., Katz, P.S., Zanesco, A., Lucchesi, P.A., Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training. Vascul. Pharmacol. 57:5–6 (2012), 187–193.
4. American Heart Association. Available from: https://www.heart.org/idc/groups/heart-public/wcm/hcm/documents/downloadable/ucm_300322.pdf.
5. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf.
6. American Diabetes, Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36:4 (2013), 1033–1046.
7. Sacks, F.M., Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction. Am. J. Cardiol. 102:12A (2008), 1L–3L.
8. Calabro, P., Golia, E., Maddaloni, V., Malvezzi, M., Casillo, B., Marotta, C., Calabro, R., Golino, P., Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?. Intern. Emerg. Med. 4:1 (2009), 25–34.
9. Donath, M.Y., Shoelson, S.E., Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11:2 (2011), 98–107.
10. Duprez, D.A., Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J. Hypertens. 24:6 (2006), 983–991.
11. Husarek, K.E., Katz, P.S., Trask, A.J., Galantowicz, M.L., Cismowski, M.J., Lucchesi, P.A., The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice. Vascul. Pharmacol. 76 (2016), 28–36.
12. Katz, P.S., Trask, A.J., Souza-Smith, F.M., Hutchinson, K.R., Galantowicz, M.L., Lord, K.C., Stewart, J.A. Jr., Cismowski, M.J., Varner, K.J., Lucchesi, P.A., Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res. Cardiol. 106:6 (2011), 1123–1134.
13. Souza-Smith, F.M., Katz, P.S., Trask, A.J., Stewart, J.A. Jr., Lord, K.C., Varner, K.J., Vassallo, D.V., Lucchesi, P.A., Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One, 6(8), 2011, e23337.
14. Anghelescu, M., Tonniges, J.R., Calomeni, E., Shamhart, P.E., Agarwal, G., Gooch, K.J., Trask, A.J., Vascular mechanics in decellularized aortas and coronary resistance microvessels in type 2 diabetic db/db mice. Ann. Biomed. Eng. 43:11 (2015), 2760–2770.
15. Camici, P.G., Crea, F., Coronary microvascular dysfunction. N. Engl. J. Med. 356:8 (2007), 830–840.
16. Spoladore, R., Fisicaro, A., Faccini, A., Camici, P.G., Coronary microvascular dysfunction in primary cardiomyopathies. Heart 100:10 (2014), 806–813.
17. Matrougui, K., Levy, B.I., Henrion, D., Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br. J. Pharmacol. 130:3 (2000), 521–526.
18. Uematsu, M., Ohara, Y., Navas, J.P., Nishida, K., Murphy, T.J., Alexander, R.W., Nerem, R.M., Harrison, D.G., Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 269:6 Pt. 1 (1995), C1371–1378.
19. Malek, A., Izumo, S., Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am. J. Physiol. 263:2 Pt. 1 (1992), C389–396.
20. Mulvany, M.J., Vascular remodeling of resistance vessels: can we define this?. Cardiovasc. Res. 41:1 (1999), 9–13.
21. Baumbach, G.L., Heistad, D.D., Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13:6 Pt. 2 (1989), 968–972.
22. Gibbons, G.H., Dzau, V.J., The emerging concept of vascular remodeling. N. Engl. J. Med. 330:20 (1994), 1431–1438.
23. Alexander, M.R., Owens, G.K., Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 74 (2012), 13–40.
24. Owens, G.K., Kumar, M.S., Wamhoff, B.R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:3 (2004), 767–801.
25. Stegemann, J.P., Hong, H., Nerem, R.M., Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J. Appl. Physiol. 98:6 (2005), 2321–2327.
26. Sehgel, N.L., Vatner, S.F., Meininger, G.A., Smooth muscle cell stiffness syndrome-revisiting the structural basis of arterial stiffness. Front. Physiol., 6, 2015, 335.
27. Picchi, A., Capobianco, S., Qiu, T., Focardi, M., Zou, X., Cao, J.M., Zhang, C., Coronary microvascular dysfunction in diabetes mellitus: a review. World J. Cardiol. 2:11 (2010), 377–390.
28. Bratz, I.N., Dick, G.M., Tune, J.D., Edwards, J.M., Neeb, Z.P., Dincer, U.D., Sturek, M., Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 294:6 (2008), H2489–2496.
29. Bagi, Z., Koller, A., Kaley, G., Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am. J. Physiol. Heart C. 285:4 (2003), H1404–H1410.
30. Gao, X., Belmadani, S., Picchi, A., Xu, X.B., Potter, B.J., Tewari-Singh, N., Capobianco, S., Chilian, W.M., Zhang, C.H., Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115:2 (2007), 245–254.
31. Kassan, M., Choi, S.K., Galan, M., Bishop, A., Umezawa, K., Trebak, M., Belmadani, S., Matrougui, K., Enhanced NF-kappaB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes 62:6 (2013), 2078–2087.
32. Lu, X., Guo, X.M., Karathanasis, S.K., Zimmerman, K.M., Onyia, J.E., Peterson, R.G., Kassab, G.S., Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats. Cardiovasc. Diabetol., 9, 2010.
33. Wynne, B.M., Labazi, H., Tostes, R.C., Webb, R.C., Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacol. Res. 65:1 (2012), 41–47.
34. Toque, H.A., Nunes, K.P., Yao, L., Xu, Z., Kondrikov, D., Su, Y., Webb, R.C., Caldwell, R.B., Caldwell, R.W., Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function. PLoS One, 8(8), 2013, e72277.
35. Cassuto, J., Dou, H., Czikora, I., Szabo, A., Patel, V.S., Kamath, V., Belin de Chantemele, E., Feher, A., Romero, M.J., Bagi, Z., Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients. Diabetes 63:4 (2014), 1381–1393.
36. El-Remessy, A.B., Abou-Mohamed, G., Caldwell, R.W., Caldwell, R.B., High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest. Ophthalmol. Vis. Sci. 44:7 (2003), 3135–3143.
37. Delbin, M.A., Trask, A.J., The diabetic vasculature: physiological mechanisms of dysfunction and influence of aerobic exercise training in animal models. Life Sci. 102:1 (2014), 1–9.
38. Cosentino, F., Eto, M., De Paolis, P., van der Loo, B., Bachschmid, M., Ullrich, V., Kouroedov, A., Gatti, C.D., Joch, H., Volpe, M., Luscher, T.F., High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells—role of protein kinase C and reactive oxygen species. Circulation 107:7 (2003), 1017–1023.
39. Bhatta, A., Yao, L., Toque, H.A., Shatanawi, A., Xu, Z., Caldwell, R.B., Caldwell, R.W., Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function. PLoS One, 10(3), 2015, e0121727.
40. Hayden, M.R., Sowers, J.R., Tyagi, S.C., The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc. Diabetol., 2005, 2005.
41. Payne, R.A., Webb, D.J., Arterial blood pressure and stiffness in hypertension: is arterial structure important?. Hypertension 48:3 (2006), 366–367.
42. Schiffrin, E.L., Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 59:2 (2012), 367–374.
43. Intengan, H.D., Schiffrin, E.L., Vascular remodeling in hypertension: roles of apoptosis, inflammation and fibrosis. Hypertension 38:3 Pt. 2 (2001), 581–587.
44. Trask, A.J., Katz, P.S., Kelly, A.P., Galantowicz, M.L., Cismowski, M.J., West, T.A., Neeb, Z.P., Berwick, Z.C., Goodwill, A.G., Alloosh, M., Tune, J.D., Sturek, M., Lucchesi, P.A., Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J. Appl. Physiol. (1985) 113:7 (2012), 1128–1140.
45. Villalba, N., Martinez, P., Briones, A.M., Sanchez, A., Salaices, M., Garcia-Sacristan, A., Hernandez, M., Benedito, S., Prieto, D., Differential structural and functional changes in penile and coronary arteries from obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 297:2 (2009), H696–707.
46. De Ciuceis, C., Amiri, F., Brassard, P., Endemann, D.H., Touyz, R.M., Schiffrin, E.L., Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler. Thromb. Vasc. Biol. 25:10 (2005), 2106–2113.
47. Ko, E.A., Amiri, F., Pandey, N.R., Javeshghani, D., Leibovitz, E., Touyz, R.M., Schiffrin, E.L., Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 292:4 (2007), H1789–1795.
48. Hanna, M.A., Taylor, C.R., Chen, B., La, H.S., Maraj, J.J., Kilar, C.R., Behnke, B.J., Delp, M.D., Muller-Delp, J.M., Structural remodeling of coronary resistance arteries: effects of age and exercise training. J. Appl. Physiol. (1985) 117:6 (2014), 616–623.
49. Lipes, M.A., Galderisi, A., Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes. Curr. Diab. Rep., 15(5), 2015, 30.
50. Pourageaud, F., Crabos, M., Freslon, J.L., The elastic modulus of conductance coronary arteries from spontaneously hypertensive rats is increased. J. Hypertens. 15:10 (1997), 1113–1121.
51. Roque, F.R., Briones, A.M., Garcia-Redondo, A.B., Galan, M., Martinez-Revelles, S., Avendano, M.S., Cachofeiro, V., Fernandes, T., Vassallo, D.V., Oliveira, E.M., Salaices, M., Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension. Br. J. Pharmacol. 168:3 (2013), 686–703.
52. Arnalich-Montiel, A., Gonzalez, M.C., Delgado-Baeza, E., Delgado-Martos, M.J., Condezo-Hoyos, L., Martos-Rodriguez, A., Rodriguez-Rodriguez, P., Quintana-Villamandos, B., Short-term esmolol improves coronary artery remodeling in spontaneously hypertensive rats through increased nitric oxide bioavailability and superoxide dismutase activity. BioMed Res. Int., 2014, 2014, 531087.
53. Quintana-Villamandos, B., Arnalich-Montiel, A., Arribas, S., Luneburg, N., Boger, R.H., Delgado-Martos, M.J., Fernandez-Criado, C., Delgado-Baeza, E., Gonzalez, M.C., Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats. Hypertens. Res., 2016.
54. Picchi, A., Gao, X., Belmadani, S., Potter, B.J., Focardi, M., Chilian, W.M., Zhang, C., Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 99:1 (2006), 69–77.
55. Rudic, R.D., Shesely, E.G., Maeda, N., Smithies, O., Segal, S.S., Sessa, W.C., Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101:4 (1998), 731–736.
56. Hale, S.A., Weger, L., Mandala, M., Osol, G., Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition. Am. J. Physiol. Heart Circ. Physiol. 301:4 (2011), H1266–1275.
57. Myers, P.R., Tanner, M.A., Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide. Arterioscler. Thromb. Vasc. Biol. 18:5 (1998), 717–722.
58. Tronc, F., Mallat, Z., Lehoux, S., Wassef, M., Esposito, B., Tedgui, A., Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler. Thromb. Vasc. Biol. 20:12 (2000), E120–126.
59. Hong, Z., Reeves, K.J., Sun, Z., Li, Z., Brown, N.J., Meininger, G.A., Vascular smooth muscle cell stiffness and adhesion to collagen I modified by vasoactive agonists. PLoS One, 10(3), 2015, e0119533.
60. Numaguchi, K., Egashira, K., Takemoto, M., Kadokami, T., Shimokawa, H., Sueishi, K., Takeshita, A., Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 26:6 Pt. 1 (1995), 957–962.
61. Quintana-Villamandos, B., Gonzalez, M.C., Delgado-Martos, M.J., Condezo-Hoyos, L., Boger, R.H., Luneburg, N., Pazo-Sayos, L., Gutierrez-Arzapalo, P.Y., Delgado-Baeza, E., Short-term esmolol attenuates remodeling of the thoracic aorta in hypertensive rats by decreasing concentrations of ADMA down-regulated by oxidative stress. Eur. J. Pharmacol. 791 (2016), 502–509.
62. Elms, S.C., Toque, H.A., Rojas, M., Xu, Z., Caldwell, R.W., Caldwell, R.B., The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia 56:3 (2013), 654–662.
63. Toque, H.A., Nunes, K.P., Rojas, M., Bhatta, A., Yao, L., Xu, Z., Romero, M.J., Webb, R.C., Caldwell, R.B., Caldwell, R.W., Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension. Front. Immunol., 4, 2013, 219.
64. Wang, W., Hein, T.W., Zhang, C., Zawieja, D.C., Liao, J.C., Kuo, L., Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase I. Microcirculation 18:1 (2011), 36–45.
65. Cho, Y.E., Basu, A., Dai, A., Heldak, M., Makino, A., Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice. Am. J. Physiol. Cell Physiol. 305:10 (2013), C1033–1040.
66. Virdis, A., Neves, M.F., Amiri, F., Touyz, R.M., Schiffrin, E.L., Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22:3 (2004), 535–542.
67. Wang, C., Luo, Z., Kohan, D., Wellstein, A., Jose, P.A., Welch, W.J., Wilcox, C.S., Wang, D., Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney disease. Hypertension 65:5 (2015), 1055–1063.
68. Staiculescu, M.C., Foote, C., Meininger, G.A., Martinez-Lemus, L.A., The role of reactive oxygen species in microvascular remodeling. Int. J. Mol. Sci. 15:12 (2014), 23792–23835.
69. Nunes, K.P., Labazi, H., Webb, R.C., New insights into hypertension-associated erectile dysfunction. Curr. Opin. Nephrol. Hypertens. 21:2 (2012), 163–170.
70. Wynne, B.M., Chiao, C.W., Webb, R.C., Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1. J. Am. Soc. Hypertens. 3:2 (2009), 84–95.
71. Hong, Z., Sun, Z., Li, Z., Mesquitta, W.T., Trzeciakowski, J.P., Meininger, G.A., Coordination of fibronectin adhesion with contraction and relaxation in microvascular smooth muscle. Cardiovasc. Res. 96:1 (2012), 73–80.
72. Potthoff, S.A., Stamer, S., Grave, K., Konigshausen, E., Sivritas, S.H., Thieme, M., Mori, Y., Woznowski, M., Rump, L.C., Stegbauer, J., Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension. J. Renin Angiotensin Aldosterone Syst., 17(3), 2016.
73. Cousin, M., Custaud, M.A., Baron-Menguy, C., Toutain, B., Dumont, O., Guihot, A.L., Vessieres, E., Subra, J.F., Henrion, D., Loufrani, L., Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension 55:1 (2010), 109–115.
74. Sun, H., Zhao, Y., Bi, X., Li, S., Su, G., Miao, Y., Ma, X., Zhang, Y., Zhang, W., Zhong, M., Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats. Diagn. Pathol., 10, 2015, 18.
75. Nakashima, T., Umemoto, S., Yoshimura, K., Matsuda, S., Itoh, S., Murata, T., Fukai, T., Matsuzaki, M., TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase. Hypertens. Res. 38:10 (2015), 649–655.
76. Bihl, J.C., Zhang, C., Zhao, Y., Xiao, X., Ma, X., Chen, Y., Chen, S., Zhao, B., Chen, Y., Angiotensin-(1–7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: role of the NFsmall ka, CyrillicB inflammatory pathway. Vascul. Pharmacol. 73 (2015), 115–123.
77. Foulquier, S., Steckelings, U.M., Unger, T., Impact of the AT(2) receptor agonist C21 on blood pressure and beyond. Curr. Hypertens. Rep. 14:5 (2012), 403–409.
78. Paulis, L., Becker, S.T., Lucht, K., Schwengel, K., Slavic, S., Kaschina, E., Thone-Reineke, C., Dahlof, B., Baulmann, J., Unger, T., Steckelings, U.M., Direct angiotensin II type 2 receptor stimulation in Nomega-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension 59:2 (2012), 485–492.
79. Santos, R.A., Ferreira, A.J., Verano-Braga, T., Bader, M., Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 216:2 (2013), R1–R17.
80. Trask, A.J., Ferrario, C.M., Angiotensin-(1–7): pharmacology and new perspectives in cardiovascular treatments. Cardiovasc. Drug Rev. 25:2 (2007), 162–174.
81. Zhang, Z., Chen, L., Zhong, J., Gao, P., Oudit, G.Y., ACE2/Ang-(1–7) signaling and vascular remodeling. Sci. China Life Sci. 57:8 (2014), 802–808.
82. Sachidanandam, K., Hutchinson, J.R., Elgebaly, M.M., Mezzetti, E.M., Dorrance, A.M., Motamed, K., Ergul, A., Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:4 (2009), R952–959.
83. Bohm, F., Pernow, J., The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc. Res. 76:1 (2007), 8–18.
84. Ferri, C., Bellini, C., Desideri, G., Baldoncini, R., Properzi, G., Santucci, A., De Mattia, G., Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp. Clin. Endocrinol. Diabetes 105:Suppl. 2 (1997), 38–40.
85. Knudson, J.D., Rogers, P.A., Dincer, U.D., Bratz, I.N., Araiza, A.G., Dick, G.M., Tune, J.D., Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome. Microcirculation 13:3 (2006), 209–218.
86. Sachidanandam, K., Portik-Dobos, V., Kelly-Cobbs, A.I., Ergul, A., Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes. Can. J. Physiol. Pharmacol. 88:6 (2010), 616–621.
87. Pu, Q., Neves, M.F., Virdis, A., Touyz, R.M., Schiffrin, E.L., Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42:1 (2003), 49–55.
88. Schmidt, A.M., Yan, S.D., Wautier, J.L., Stern, D., Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84:5 (1999), 489–497.
89. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., Cerami, A., Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:4758 (1986), 1629–1632.
90. Zieman, S.J., Melenovsky, V., Kass, D.A., Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25:5 (2005), 932–943.
91. Kass, D.A., Shapiro, E.P., Kawaguchi, M., Capriotti, A.R., Scuteri, A., deGroof, R.C., Lakatta, E.G., Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104:13 (2001), 1464–1470.
92. Aronson, D., Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 21:1 (2003), 3–12.
93. Grossin, N., Auger, F., Niquet-Leridon, C., Durieux, N., Montaigne, D., Schmidt, A.M., Susen, S., Jacolot, P., Beuscart, J.B., Tessier, F.J., Boulanger, E., Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol. Nutr. Food Res. 59:5 (2015), 927–938.
94. Serban, A.I., Stanca, L., Geicu, O.I., Munteanu, M.C., Dinischiotu, A., RAGE and TGF-beta1 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGEs exposed fibroblast cells. PLoS One, 11(3), 2016, e0152376.
95. Gao, X., Zhang, H., Schmidt, A.M., Zhang, C., AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 295:2 (2008), H491–498.
96. Liu, Y., Yu, M., Zhang, L., Cao, Q., Song, Y., Liu, Y., Gong, J., Soluble receptor for advanced glycation end products mitigates vascular dysfunction in spontaneously hypertensive rats. Mol. Cell. Biochem. 419:1–2 (2016), 165–176.
97. Chaabane, C., Heizmann, C.W., Bochaton-Piallat, M.L., Extracellular S100A4 induces smooth muscle cell phenotypic transition mediated by RAGE. Biochim. Biophys. Acta 1853:9 (2015), 2144–2157.
98. Guzik, T.J., Hoch, N.E., Brown, K.A., McCann, L.A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., Harrison, D.G., Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204:10 (2007), 2449–2460.
99. Marvar, P.J., Thabet, S.R., Guzik, T.J., Lob, H.E., McCann, L.A., Weyand, C., Gordon, F.J., Harrison, D.G., Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ. Res. 107:2 (2010), 263–270.
100. Lee, S., Park, Y., Zhang, C., Exercise training prevents coronary endothelial dysfunction in type 2 diabetic mice. Am. J. Biomed. Sci. 3:4 (2011), 241–252.
101. Zhang, C., Park, Y., Picchi, A., Potter, B.J., Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice. Basic Res. Cardiol. 103:5 (2008), 407–416.
102. Park, Y., Capobianco, S., Gao, X., Falck, J.R., Dellsperger, K.C., Zhang, C., Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 295:5 (2008), H1982–1988.
103. Heiss, E.H., Liu, R., Waltenberger, B., Khan, S., Schachner, D., Kollmann, P., Zimmermann, K., Cabaravdic, M., Uhrin, P., Stuppner, H., Breuss, J.M., Atanasov, A.G., Dirsch, V.M., Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylation. Sci. Rep., 6, 2016, 20771.
104. Ogawa, A., Firth, A.L., Yao, W., Rubin, L.J., Yuan, J.X., Prednisolone inhibits PDGF-induced nuclear translocation of NF-kappaB in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:4 (2008), L648–657.
105. Singh, P., Zheng, X.L., Dual regulation of myocardin expression by tumor necrosis factor-alpha in vascular smooth muscle cells. PLoS One, 9(11), 2014, e112120.
106. De Martin, R., Hoeth, M., Hofer-Warbinek, R., Schmid, J.A., The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler. Thromb. Vasc. Biol. 20:11 (2000), E83–88.